News
Are HMAS appropriate for posttransplant maintenance in acute leukemias?
- Author:
- Randy Dotinga
Not yet, hematologist/oncologist tells colleagues at ALF meeting.
News
Novel agents hold promise for frontline AML treatment
- Author:
- Randy Dotinga
It’s time to move them beyond relapsed/refractory setting, leukemia specialist tells colleagues.
News
Novel treatments under study for chronic graft-versus-host disease in allo-HCT
- Author:
- Randy Dotinga
For now, though, options other than corticosteroids are limited, a hematologist-oncologist said.
News
Standard treatment lacking in relapsed refractory AML
- Author:
- Randy Dotinga
Clinical trials are still the best strategy, says a hematologist/oncologist.
News
Can AML patients be too old for cell transplantation?
- Author:
- Randy Dotinga
Age shouldn’t be a crucial deciding factor, a hematologist/oncologist tells colleagues.
News
Landmark sickle cell report targets massive failures, calls for action
- Author:
- Randy Dotinga
Success in increasing the survival of children with SCD has not been translated into similar success as they...
Article
Promising Trends Seen in AIDS-Associated NHL
- Author:
- Randy Dotinga
Patients are doing as well as HIV-negative counterparts in some cases, hematologist says at virtual AVAHO meeting.
Article
One Year In, Mission Act Transforms Community Care for Veterans
- Author:
- Randy Dotinga
Third-party administrators are key to helping veterans receive care at civilian facilities, VA official tells AVAHO audience.
Article
HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades
- Author:
- Randy Dotinga
Radiotherapy-cisplatin combo is boosting survival in certain patients, head and neck surgeon tells AVAHO Virtual Meeting...
Article
COVID-19 and Blood Clots: Inside the Battle to Save Patients
- Author:
- Randy Dotinga
Protocols are now in place to prevent thrombosis, hematologist-oncologist tells colleagues at AVAHO Virtual Meeting.
Article
VA Looks to Increase Real-World Impact of Clinical Research
- Author:
- Randy Dotinga
News
In MS, serious adverse effects are more common in rituximab versus ocrelizumab
- Author:
- Randy Dotinga
Infection rates are high among reported AEs, and related deaths weren’t uncommon, researchers reported.
News
Obesity boosts risks in COVID-19 from diagnosis to death
- Author:
- Randy Dotinga
Excess pounds are linked to excess infection, hospitalization, ICU admission, and mortality.
News
Report touts PFO closure in divers; experts disagree
- Author:
- Randy Dotinga
But physicians say findings are incomplete and don’t agree with advice about procedures.
News
Multiple traits more common in difficult-to-treat patients with migraine
- Author:
- Randy Dotinga
Difficult-to-treat patients are more likely to have comorbid depression and to delay acute treatment.